van der Weyden, Carrie <br/><br/>
High-dose thiotepa-based conditioning regimens for relapsed lymphoma involving the central nervous system: from "orphan drug" to a standard-of-care?  [electronic resource] 

 -  Leukemia & lymphoma  2016 
 - 1-3 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2015.1058937  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Central Nervous System Neoplasms--drug therapy<br/>Humans<br/>Lymphoma--drug therapy<br/>Nervous System<br/>Orphan Drug Production<br/>Thiotepa--therapeutic use<br/>Transplantation Conditioning